We would like to thank all of you for the overwhelming response to our call for abstracts for the 3rd MIM Pan-African Conference to be held in Arusha, Tanzania, 18-22 November 2002. The Conference titled "Global Advances in Malaria Research: Developing Evidence-Based Policy and Control" aims to promote the exchange of scientific ideas and will focus on scientific progress and potential in malaria research, with special emphasis given to the linkage between malaria research and its contribution to evidence based policy and control. Due to several requests we have decided to extend the deadline for abstract submission until Sunday May 12; after May 12th the online abstract submission site will close. We are therefore encouraging those who missed the May 1 deadline to use this extension to submit abstracts. Please do not resubmit a revised version of an abstract you have already submitted. In particular, we would like to see more abstracts in the following areas:
Extension of deadline for abstracts for the 3rd MIM Pan-African Conference
--------------------------------------------------------------------------
Dear Colleagues,
We would like to thank all of you for the overwhelming response to
our call for abstracts for the 3rd MIM Pan-African Conference to be
held in Arusha, Tanzania, 18-22 November 2002. The Conference titled
"Global Advances in Malaria Research: Developing Evidence-Based Pol-
icy and Control" aims to promote the exchange of scientific ideas and
will focus on scientific progress and potential in malaria research,
with special emphasis given to the linkage between malaria research
and its contribution to evidence based policy and control.
Due to several requests we have decided to extend the deadline for
abstract submission until Sunday May 12; after May 12th the online
abstract submission site will close. We are therefore encouraging
those who missed the May 1 deadline to use this extension to submit
abstracts. Please do not resubmit a revised version of an abstract
you have already submitted. In particular, we would like to see more
abstracts in the following areas:
Vaccine development
1) Any aspect related to vaccine research and development
2) Global vaccine policy issues
2) Strengthening capacity at vaccine field trial sites
Cross-Cutting Issues
1) Malaria in complex emergencies
2) Information/monitoring and evaluations
3) Issues related to bio-ethics
4) Research capacity building
Abstracts must be text only, limited to 250 words, and only submitted
once. No charts, graphs, or other figures should be included in the
abstract. They should be submitted in Times New Roman 11.
Submit your abstract online - Go to the MIM Conference web site at:
http://mim.nih.gov/english/events/3rd_mim_conf/call_for_abstracts.html
- click on submitting abstract. If you are not applying for support
from MIM to attend the Conference you can register online now. For
those applying for sponsorship from MIM you will need to submit an
abstract which will be reviewed by a panel of experts and a limited
number of people will be selected to receive sponsorship to attend
the conference.
If you are experiencing problems with submitting your abstract
online, or can not submit your abstract online, contact the address
below directly rather than contacting the MIM Secretariat:
MIM Malaria Conference
2025 M Street NW, Suite 800
Washington, DC 20036, USA
Tel: +1-202-331-2000
Fax: +1-202-331-0111
mailto:[email protected]
I am looking forward to seeing you in Arusha.
Best regards,
Martin Sarikiael Alilio, PhD
Multilateral Initiative on Malaria
Fogarty International Center
National Institutes of Health
31 Center Drive MSC 2220
Building 31, Room B2C39
Bethesda, MD 20892, USA
Fax: +1-301-402-2056
Tel: +1-301-402-6212
mailto:[email protected]
--
To send a message to AFRO-NETS, write to: [email protected]
To subscribe or unsubscribe, write to: [email protected]
in the body of the message type: subscribe afro-nets OR unsubscribe
afro-nets
To contact a person, send a message to: [email protected]
Information and archives: http://www.afronets.org
- Log in to post comments
- 833 reads